Montanide (Registered Trademark) ISA-51 VG Adjuvant

SUSPENDED · PHASE1, PHASE2 · Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinomas

Revisions to eligibility/design being made prior to enrollment of first participants.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.